Lumateperone for Depression Linked to Bipolarity and Major Depression
About this title
Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder
Read the official source — NCT04285515Researchers compared Lumateperone and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Understand this study
What did researchers investigate?
Researchers compared Lumateperone and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- Garden Grove and 41 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 488
- Sponsor
- Intra-Cellular Therapies, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Bulgaria, Russia, ...
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT04285515
- Official title
Show the full official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) or Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Garden Grove, United States · Oceanside, United States · Sherman Oaks, United States
32 more locations
- Lauderhill, United States
- Miami, United States
- Orange City, United States
- Atlanta, United States
- Decatur, United States
- O'Fallon, United States
- Cedarhurst, United States
- New York, United States
- Charlotte, United States
- Bellevue, United States
- Burgas, Bulgaria
- Kardzhali, Bulgaria
- Plovdiv, Bulgaria
- Rousse, Bulgaria
- Sofia, Bulgaria
- Varna, Bulgaria
- Veliko Tarnovo, Bulgaria
- Vratsa, Bulgaria
- Moscow, Russia
- Saint Petersburg, Russia
- Tomsk, Russia
- Yekaterinburg, Russia
- Belgrade, Serbia
- Kovin, Serbia
- Kragujevac, Serbia
- Kyiv, Ukraine
- Lviv, Ukraine
- Odesa, Ukraine
- Poltava, Ukraine
- Smila, Ukraine
- Vinnytsia, Ukraine
- Russia
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Lumateperone and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
Who is behind this study?
The study sponsor is Intra-Cellular Therapies, Inc.
Did this study involve medication?
Yes. The study involved medication, including Lumateperone and Placebos.
Who was this study for?
Listed age limits: 18 years to 75 years.
